Navigation Links
Law Offices of Howard G. Smith Announces 21 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Vertex Pharmaceuticals Inc.
Date:4/21/2008

BENSALEM, Pa., April 21 /PRNewswire/ -- Law Offices of Howard G. Smith announces a May 12, 2008, deadline to move to be a lead plaintiff in the securities class action lawsuit filed on behalf of all persons who purchased the publicly traded securities of Vertex Pharmaceuticals Inc. ("Vertex" or the "Company") (Nasdaq: VRTX) between June 12, 2007 and November 2, 2007, inclusive (the "Class Period"). The shareholder lawsuit is pending in the United States District Court for the District of Massachusetts.

The Complaint alleges that the defendants violated federal securities laws by issuing material misrepresentations to the market concerning the Company's operations and prospects, thereby artificially inflating the price of Vertex securities.

No class has yet been certified in the above action. Until a class is certified, you are not represented by counsel unless you retain one. If you purchased the publicly traded securities of Vertex between June 12, 2007 and November 2, 2007, you have certain rights, and have until May 12, 2008, to move for Lead Plaintiff status. To be a member of the class you need not take any action at this time, and you may retain counsel of your choice. If you wish to discuss this action or have any questions concerning this Notice or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215)638-4847, Toll-Free at (888)638-4847, by email to howardsmithlaw@hotmail.com or visit our website at http://www.howardsmithlaw.com.


'/>"/>
SOURCE Law Offices of Howard G. Smith
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against LCA-Vision Inc.
2. The Law Offices of John David Hart: Texas Man Sues Medtronic in Body-Snatching Case
3. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Micrus Endovascular Corporation
4. Demonstration at Carlyle Group Offices Monday as Grassroots Caravan of Caregivers, Senior Advocates Arrives in D.C. to Speak Out for Improved Care, Staffing at Nations Largest Nursing Home Chain
5. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against WellCare Health Plans, Inc.
6. Law Offices of Howard G. Smith Announces 14 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Care Investment Trust Inc.
7. Northern Fertility & Reproductive Associates Adds Two Local Infertility Specialists to Staff, Opens New Offices In Center City And Blue Bell
8. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Micrus Endovascular Corporation
9. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Threshold Pharmaceuticals, Inc.
10. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Security Capital Assurance Ltd.
11. OrthoSynetics(TM) Opens Regional Offices in Dallas, Atlanta
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...re-FirstCall/ -- The Board of Directors of Tyco In...ared a regular quarterly cash dividend of $0.20 pe...ry 2, 2009, to shareholders of record as of Januar..., Tyco International (NYSE: TYC ) is a divers... and services to customers in more than 60 countri...
(Date:12/4/2008)... the wake of the findings of its 5th,Internationa...dvances in,nutrition and its importance in elite ...esearch program on the specific nutritional needs ... The program will provide data to help,support a ...the future, which,should lead to a new generation...
(Date:12/4/2008)...studies into the practice of forcing psychiatric p...w showed that there have been very few rigorous in...blished in the latest Journal of Advanced Nursing...tion (CM) are more likely to be in their thirties ...r or another psychotic disorder. , CM is used m...
(Date:12/4/2008)...Stem cells derived from bone marrow may serve as a...ed epidermolysis bullosa (EB), a disorder charact...to a study prepublished online in Blood , the o...ogy. Epidermolysis bullosa is a disorder charac...ering on touch, akin to third degree burns. While ...
Breaking Medicine News(10 mins):Health News:Nestle Launches New Research Program on the Specific Nutritional Needs of Athletes 2Health News:Nestle Launches New Research Program on the Specific Nutritional Needs of Athletes 3Health News:Coerced medication used in psychiatric care despite lack of clinical evidence 2Health News:Coerced medication used in psychiatric care despite lack of clinical evidence 3Health News:Bone marrow-derived stem cells may offer novel therapeutic option for skin disorder 2Health News:Bone marrow-derived stem cells may offer novel therapeutic option for skin disorder 3
...la virus in its latest outbreak has claimed around...istry officials in Kampala. More shocking is the ...luding doctors & nurses. But what shocked the nat... a prominent doctor spearheading the fight against...
, which is a much talked about topic, considering that the mapping of the genes will enable one to have the information to manipulate individual characteristics like the color of the eye or even skin.
...he December issue of the Journal of Infectious Dis...peripheral blood mononuclear cells (PBMCs) from in...ed to PBMCs from infected patients treated with an...th and her team at the National Institute of Aller...
... the heart attack patients should get an immediate...ood flow to their hearts. Cleveland Clinic cardio...of more than 12,000 heart disease patients and fou...l count is in what is considered a "high normal ra...
Other Medicine News:
(Date:12/2/2008)...Dec. 2 Biopure Corporati.... Naval Medical Research Center,(NMRC) has submit...vised,investigational new drug (IND) application ...en therapeutic Hemopure(R) [hemoglobin glutamer - ...eatment of trauma patients. The study is,entitled...
(Date:12/1/2008)...RNewswire-USNewswire/ -- New research has found th...uted tomography (CT) scanner in an emergency room ...ctims who receive a potentially life-saving treatm...e Medical Center (NSMC)-Salem Hospital in Salem, M...g of the Radiological Society of North America (RS...
(Date:12/1/2008)... 1 Roche announced today that a,c... in perceived pain and,discomfort associated with...cose monitoring systems and lancing devices were d...at, overall, the ACCU-CHEK Aviva and ACCU-CHEK Com...e ACCU-CHEK Multiclix, ACCU-CHEK,Softclix and ACC...
(Date:12/1/2008)...mark, December 1 Followi... intent to procure an MVA-based,third generation...vices,Canada, on behalf of the Canadian Departmen...Bavarian Nordic for the delivery of IMVAMUNE(R). ,...AMUNE(R) as part of the,country,s bio-preparednes...
Breaking Medicine Technology:U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3New Anti Cellulite Treatment Prepares Women for Falls Short Skirts 25116 1New Anti Cellulite Treatment Prepares Women for Falls Short Skirts 25116 2New Anti Cellulite Treatment Prepares Women for Falls Short Skirts 25116 3MedCath Corporation Reports Third Quarter Earnings 25112 1MedCath Corporation Reports Third Quarter Earnings 25112 2MedCath Corporation Reports Third Quarter Earnings 25112 3MedCath Corporation Reports Third Quarter Earnings 25112 4MedCath Corporation Reports Third Quarter Earnings 25112 5MedCath Corporation Reports Third Quarter Earnings 25112 6MedCath Corporation Reports Third Quarter Earnings 25112 7MedCath Corporation Reports Third Quarter Earnings 25112 8MedCath Corporation Reports Third Quarter Earnings 25112 9MedCath Corporation Reports Third Quarter Earnings 25112 10MedCath Corporation Reports Third Quarter Earnings 25112 11MedCath Corporation Reports Third Quarter Earnings 25112 12MedCath Corporation Reports Third Quarter Earnings 25112 13MedCath Corporation Reports Third Quarter Earnings 25112 14MedCath Corporation Reports Third Quarter Earnings 25112 15MedCath Corporation Reports Third Quarter Earnings 25112 16Ortho McNeil initiates first of its kind skin infection registry 25110 1Ortho McNeil initiates first of its kind skin infection registry 25110 2Interleukin Genetics Announces Conference Call and Webcast to Discuss Second Quarter 2008 Business Results 6987 1Interleukin Genetics Announces Conference Call and Webcast to Discuss Second Quarter 2008 Business Results 6987 2
...April 09, 2007 /PRNewswire/ -- Nereus,Pharmaceutic...ment,from marine microbial sources, and its collab...y results involving its cancer drug,candidates at ...l,Meeting in Los Angeles April 14-18. Four posters...hanisms and anti-tumor,activity in several tumor m...
... EXTON, Pa.--(BUSINESS WIRE)--Apr 9, 2007 -,GlaxoS...n,(Nasdaq:ADLR) today announced data from Study 76...velopment program for,alvimopan (Entereg/Entrareg(...controlled (12,month) study, was designed to evalu...opan 0.5 mg twice daily in patients taking,opioids...
Other Medicine Technology:Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 2Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 3Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 4Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 5GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 2GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 3GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 4GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 5GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 6GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 7
Merocel Ophthalmic Products provide the surgeon with superior fiber free products for unparalleled fluid control and safe cleaning of fine microsurgical instruments. The exclusive Merocel material is
Merocel Ophthalmic Products provide the surgeon with fiber free products for fluid,control and safe cleaning of fine microsurgical instruments. The exclusive Merocel,material is highly absorbent,
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box.
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box.
Medicine Products: